Rose Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.48M Buy
2,139
+1,701
+388% +$2.01M 0.6% 37
2026
Q2
$525K Buy
+438
New +$448K 0.26% 63

Other funds holding LLY

Rose Capital Advisors's LLY Position: Q3 2026 in Review

Rose Capital Advisors increased its Eli Lilly (LLY) stake by 388% in Q3 2026, buying an estimated $2.01M and bringing the position to 2,139 shares worth $2.48M. The position accounts for 0.6% of the portfolio, ranked #37.

Rose Capital Advisors first reported a position in LLY in Q2 2026 and has held it in 2 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Rose Capital Advisors held 2,139 shares of Eli Lilly worth $2.48M as of Q3 2026.
  • Rose Capital Advisors bought 1,701 Eli Lilly shares in Q3 2026, an estimated $2.01M.
  • Eli Lilly made up 0.6% of Rose Capital Advisors's portfolio in Q3 2026, its #37 holding.
  • Rose Capital Advisors first reported a position in Eli Lilly in Q2 2026 and has held it in 2 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Rose Capital Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.